Insider · CIK 0001743122
Samantha Prout
Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing Dec 28, 2023, latest Dec 28, 2023.
In brief
Samantha Prout files SEC Form 4 as officer at FOLD (AMICUS THERAPEUTICS, INC.). Since Dec 28, 2023, Samantha Prout has reported 0 open-market buys worth $0 and 1 open-market sell worth $107k, the latest filed on Dec 28, 2023.
A track record needs three past buys with six months of prices behind them; Samantha Prout has 0, so none is measured yet.
The newest scored trade: sold $107k of FOLD on Dec 26, 2023, filed Dec 28, 2023, scored 20 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | AMICUS THERAPEUTICS, INC. | $107k 7,659 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 26, 2023 | FOLD AMICUS THERAPEUTICS INC | 7,659 0.00% of outstanding | $104k | Dec 26, 2023 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -125,951 | $14.50 | $1.8M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -2,526 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -3,176 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -37,810 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -55,203 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -43,592 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -62,715 | - | - | 0 | Apr 27, 2026 |
| Jan 2, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -3,443 | $14.27 | $49k | 138,191 | Jan 6, 2026 |
| Jan 3, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -12,240 | $14.27 | $175k | 125,951 | Jan 6, 2026 |
| Dec 1, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +32,193 | $0.00 | $0 | 141,634 | Dec 3, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +27,416 | $0.00 | $0 | 122,941 | Feb 13, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -13,500 | $9.57 | $129k | 109,441 | Feb 13, 2025 |
| Jan 2, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -3,443 | $9.31 | $32k | 70,483 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +34,614 | $0.00 | $0 | 105,097 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -8,275 | $9.41 | $78k | 96,822 | Jan 6, 2025 |
| Jan 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -1,297 | $9.41 | $12k | 95,525 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +62,715 | $0.00 | $0 | 62,715 | Jan 6, 2025 |
| Dec 26, 2023 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,659 | $14.00 | $107k | 121,912 | Dec 28, 2023 |
Questions about Samantha Prout
Answered from the filings on this page, as of the latest one.
Is Samantha Prout buying or selling?
Not in the last 12 months. Samantha Prout's latest open-market trade on SEC Form 4 was sold $107k of FOLD on Dec 26, 2023.
How did Samantha Prout's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samantha Prout has 0.
Where does Samantha Prout file Form 4?
Samantha Prout has filed Form 4 at FOLD (AMICUS THERAPEUTICS, INC.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.